109 related articles for article (PubMed ID: 18066823)
1. 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against wide spectrum of HIV-1 strains, favorable toxic profiles, and stability in plasma.
Ohrui H; Kohgo S; Hayakawa H; Kodama E; Matsuoka M; Nakata T; Mitsuya H
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1543-6. PubMed ID: 18066823
[TBL] [Abstract][Full Text] [Related]
2. 2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma.
Ohrui H; Kohgo S; Hayakawa H; Kodama E; Matsuoka M; Nakata T; Mitsuya H
Nucleic Acids Symp Ser (Oxf); 2006; (50):1-2. PubMed ID: 17150787
[TBL] [Abstract][Full Text] [Related]
3. 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicity.
Ohrui H
Chem Rec; 2006; 6(3):133-43. PubMed ID: 16795005
[TBL] [Abstract][Full Text] [Related]
4. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.
Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE
J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247
[TBL] [Abstract][Full Text] [Related]
5. Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants.
Cancio R; Mai A; Rotili D; Artico M; Sbardella G; Clotet-Codina I; Esté JA; Crespan E; Zanoli S; Hübscher U; Spadari S; Maga G
ChemMedChem; 2007 Apr; 2(4):445-8. PubMed ID: 17323401
[No Abstract] [Full Text] [Related]
6. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
Wińska P; Miazga A; Poznański J; Kulikowski T
Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
8. Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses.
Tang G; Kertesz DJ; Yang M; Lin X; Wang Z; Li W; Qiu Z; Chen J; Mei J; Chen L; Mirzadegan T; Harris SF; Villaseñor AG; Fretland J; Fitch WL; Hang JQ; Heilek G; Klumpp K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6020-3. PubMed ID: 20829038
[TBL] [Abstract][Full Text] [Related]
9. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR
J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897
[TBL] [Abstract][Full Text] [Related]
10. 2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants.
Kawamoto A; Kodama E; Sarafianos SG; Sakagami Y; Kohgo S; Kitano K; Ashida N; Iwai Y; Hayakawa H; Nakata H; Mitsuya H; Arnold E; Matsuoka M
Int J Biochem Cell Biol; 2008; 40(11):2410-20. PubMed ID: 18487070
[TBL] [Abstract][Full Text] [Related]
11. Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations.
Butini S; Brindisi M; Cosconati S; Marinelli L; Borrelli G; Coccone SS; Ramunno A; Campiani G; Novellino E; Zanoli S; Samuele A; Giorgi G; Bergamini A; Di Mattia M; Lalli S; Galletti B; Gemma S; Maga G
J Med Chem; 2009 Feb; 52(4):1224-8. PubMed ID: 19170521
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
[TBL] [Abstract][Full Text] [Related]
13. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Eur J Med Chem; 2008 Jun; 43(6):1230-6. PubMed ID: 17869386
[TBL] [Abstract][Full Text] [Related]
14. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties.
Sriram D; Bal TR; Yogeeswari P
Bioorg Med Chem; 2004 Nov; 12(22):5865-73. PubMed ID: 15498662
[TBL] [Abstract][Full Text] [Related]
16. 4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor.
Markowitz M; Sarafianos SG
Curr Opin HIV AIDS; 2018 Jul; 13(4):294-299. PubMed ID: 29697468
[TBL] [Abstract][Full Text] [Related]
17. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological properties and anti-HIV-1 activity of new pyrimidine P1,P2-dinucleotides.
Miazga A; Ziemkowski P; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):438-44. PubMed ID: 20544533
[TBL] [Abstract][Full Text] [Related]
19. The effect of NNRTIs on HIV reverse transcriptase dimerization.
Tachedjian G; Goff SP
Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Zhan P; Liu X; Fang Z; Li Z; Pannecouque C; De Clercq E
Eur J Med Chem; 2009 Nov; 44(11):4648-53. PubMed ID: 19628308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
